chrisvoncsefalvay/vaers-outcomes huggingface dataset:
presented to the emergency department secondary to weakness.  Was found to have community-acquired pneumonia and was positive for COVID-19.  Was he is fully vaccinated and his symptoms more consistent with community-acquired pneumonia and he had minimal COVID-19 issues.  He was isolated placed on broad-spectrum antibiotics and pancultures obtained.  O2 was titrated per his needs.  Hemodialysis continued as facilitated by Nephrology.  Hospital course was uncomplicated.  He was briefly on remdesivir and dexamethasone but as was not hypoxic and asymptomatic in regards COVID-19 this was discontinued prior to finishing a full course.  Was started with aggressive physical therapy.  It was felt that he would need further rehabilitation in a skilled setting with goal to possibly be discharged to assisted living at some point.  On 09/12/2021 was complaining of cough and was a little bit hypoxic.  Procalcitonin was checked and was elevated and chest x-ray showed findings consistent with new infiltrate on the left consistent possibly with pneumonia.  He was once again started on broad-spectrum antibiotics with cefepime and vancomycin.  On 09/16/2021 his procalcitonin was trending down and he was not symptomatic.  He was transition to p.o. Levaquin.  Arrangements were made for discharge to hospital manner and he was discharged to that location in stable condition with plans to continue hemodialysis as directed on 09/17/2021.
Expired doses administered to patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired doses administered to patients) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 084J21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired doses administered to patients). On 27-Jan-2022, EXPIRED PRODUCT ADMINISTERED (Expired doses administered to patients) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient is on concomitant medication but did not specify. No treatment details were reported.   This case was linked to MOD-2022-464871 (Patient Link).
1 of 2 pts vaxed from the same Tetramune lot who had an adverse event; pt recvd vax 3NOV94 & immed following vax had diff breathing;02 given; p/20mins pt was fine;recovered;
Next day tired mild fever by 5 pm chillsand fever spiking over the next hrs to 102; Next day tired mild fever by 5 pm chillsand fever spiking over the next hrs to 102; Next day tired mild fever by 5 pm chillsand fever spiking over the next hrs to 102; 12 hrs after second shot body aches,can't get out of bed and can't sleep.; 12 hrs after second shot body aches,can't get out of bed and can't sleep.; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received the second of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 10Apr2021 at 10:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure and anxiety. The patient did not have allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included valsartan (MANUFACTURER UNKNOWN), clonazepam (MANUFACTURER UNKNOWN), cyclobenzaprine hydrochloride (FLEXERIL), tocopherol (VITAMIN E), cyanocobalamin (MANUFACTURER UNKNOWN) and multivitamins (reported as multi); all for unknown indication from an unknown date and unknown if ongoing.  The patient previously received the first dose BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 20Apr2021 as a single dose for COVID-19 immunisation. On 10Apr2021 at 22:00,12 hours after second shot the patient experienced body aches, cannot get out of bed and cannot sleep. On 11Apr2021, the next day at 12:00, the patient experienced tired and mild fever. On 11Apr2021 the next day at 17:00, the patient experienced chills. The patient reported soaked two sets of night clothes and two sets of sheets. On 11Apr2021, the patient underwent body temperature test and the result was 102 (unspecified units). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events 12 hours after second shot body aches, cannot get out of bed and cannot sleep, next day tired mild fever by 5 pm chills and fever spiking over the next hours to102 was resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
A 17 YEAR OLD CAME TO GET MODERNA VACCINE. PHARMACIST DID NOT REALIZE PATIENT WAS NOT OF AGE FOR MODERNA VACCINE. PATIENT AND HIS FATHER WERE CONTACTED. NO SIDE EFFECTS AS OF NOW HAVE BEEN REPORTED BY PATIENT OR FATHER. PATIENT WOULD LIKE TO STILL RECEIVE 2ND DOSE .
h/a, stiff neck, sore throat, nausea, diarrhea, back ache, sore muscles all over; swollen glands, flushes & chills, mouth sores (2 days); light sensitive (eyes), earache;
3/7/03 @ 7pm. Red rash began to appear bilaterally on inner aspect of upper arm. Pruritis and tenderness experienced. Rash became raised a short while later. By 3/21 about 15 discrete rash were on each arm and had spread to outer aspect of biceps and several on the back of the trunk. On 3/27 same discrete rash began bilaterally on thigh. Seen by MD on 4/2. Dx: Allergy. Symptoms persisted. Seen by MD on 4/7 & Dx: erythema multiforme. Rx: Allegra & methylprednisone x6D. Within 24 hr pruritis ceased. No further rash developed. Raised rash diminished and skin became flat. Redness decreased. As of 4/11, some red rash still remained, but continued to diminish.
Pt had perfect hearing (25 db each ear) at during a hearing screening on the same day as his vaccination.  In June of 2001, after no trauma, ear infections, or other obvious reasons, pt has no hearing in his right ear.  After several hearing tests, he only hears 80-90 db in his right ear.  The doctors have confirmed ther is no trauma, no tumor, no bone damage.  There was never a concern for his hearing until June 2001.
pt recv vax 1NOV95 & 5DEC96 pt devel chicken pox;nurse describe pt as listless & cranky, but not particularly sick & being covered in spots w/about 10 on the face;
SHOT WAS RECEIVED AT10:10AM ON FEBRUARY 10, 2021..  12:30 PM THE FIRST REACTION WAS DIZZINESS TO THE POINT THAT MOM COULD NOT GET UP ALONE.  NEXT SYMPTOM WAS SEVERE CHILLS.  PAIN SWELLING AT INJECTION SITE.  DAY TWO AFTER SHOT (FEB 11,2021) DIZZINESS CONTINUED AND SEVERE CHILLING.  FINGERS TURNED BLUEISH AND WERE EXTREMELY COLD.  MOM WAS ALSO NAUSEATED THE 2ND DAY AND KEPT A VOMIT BAG CLOSE TO HER.  AT NO POINT  DID SHE HAVE A FEVER.
Hospitalization due to COVID-19 infection  7.21.21 - patient discharged to a facility.
Chest pain started two days after 2nd vaccine. CT scan of the chest showed nonocclusive subsegmental pulmonary embolism. Started on heparin infusion initially and transitioned to Xarelto.
pt said he was feeling anxious and sat near EMS,  he was a bit sweaty and anxious.  after sitting for 15minutes he felt better after getting snacks. pt decided to  leave after feeling better and more calm. staff was with patient for reassurance and observation for any reaction.
Vaccine remained in the freezer past the recommended guidelines (14 days). Once discovered, Pfizer was contacted but did not have stability data to support acceptability of the product greater than 31 days in the freezer. All patients that were administered vaccine past 31 days were contacted and given an option to be re-vaccinated based on their doctor'S recommendation or medical group guidance.
Was administered an expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Was administered an expired vaccine) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Was administered an expired vaccine). On 20-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Was administered an expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications provided. No treatment medications provided.
Tinnitinus started in April. Beating on right side of head, Followed up by ringing in ear
EYE LID SWELLING; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING OF EYELID (EYE LID SWELLING) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING OF EYELID (EYE LID SWELLING). At the time of the report, SWELLING OF EYELID (EYE LID SWELLING) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication included eye drops. No treatment information was reported. The reporter stated that the patient experienced eye lid swelling after receiving the vaccine but the doctors said it was not because of eye drop medication. Then when the patient used the eye drop medication again, he experienced it again so the reporter stated that it was not because of Moderna vaccine.
Developed severe headache after AVA #2 that lasted for 1 week intermittently.  Continues with new onset headache syndrome now - has headaches 2 times a week and developed another migraine recently.  Flu-like symptoms greater 96 hours, headache, migraine, nausea without vomiting.
This spontaneous case was reported by a consumer and describes the occurrence of EAR PAIN (Left ear pain), PAIN IN JAW (Pain at jawline), VACCINATION SITE ERYTHEMA (Redness at left arm) and ARTHRALGIA (Left shoulder pain) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 034F21A) for COVID-19 vaccination. Concurrent medical conditions included Drug allergy (Allergic to sulfa products). On 03-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EAR PAIN (Left ear pain), PAIN IN JAW (Pain at jawline), VACCINATION SITE ERYTHEMA (Redness at left arm) and ARTHRALGIA (Left shoulder pain). At the time of the report, EAR PAIN (Left ear pain), PAIN IN JAW (Pain at jawline), VACCINATION SITE ERYTHEMA (Redness at left arm) and ARTHRALGIA (Left shoulder pain) outcome was unknown.    The patient who received Moderna Covid-19 booster shot on 03-Dec-2021 was reporting adverse event. The patient reported left shoulder pain, left ear pain, redness at left arm injection site and pain at jawline. No pre-existing condition was reported. allergic to sulfa products.No Concomitant product use was reported.No treatment information was provided.
About a week and a half after receiving my first covid vaccine, I started to feel symptoms of urinary frequency and urgency and it eventually turned into pain as well. I was diagnosed with interstitial cystitis. I was completely healthy before this?runner, yoga, eat very healthy/farmers market, meditate. And no one in my family has this. It literally came on overnight.  There is one other person in my area who said she was diagnosed with IC as well, although hers was after the booster shot, and she felt symptoms the same day.
Pain in arch of left foot. Diagnosed as Plantar Fasciitis on 10/30/2014. Four injections over two months. Saw Orthopedic Foot & Ankle specialist 05/26/2015. After several injections and ASTM physical therapy over most of the year still with same pain. Wore rocker boot all of December 2015. After EMG testing, received Platelet-Rich-Plasma (PRP) injection on 02/25/2016. Foot is somewhat better as of 03/25/2016, but still not healed. Waiting for more improvement.
I would like to start out by saying that I am well aware that this vaccine is known to cause side effects and that the benefits of the vaccine far outweigh any side effects induced by it. The reason I am writing this is to provide information that you all can keep in mind as you provide guidance on your recommendations for the timing of when the vaccine should be administered to those who have already tested positive for COVID. I tested positive for COVID-19 11 days prior to getting vaccinated. My symptoms from the virus began on 12/21/20, lasted until 12/26/20 and included: mild headache, fever of 100.3, moderate muscle fatigue, lymphadenopathy, and sinus congestion. I received the Pfizer vaccine on 1/3/21 at 11am and by 2am on 1/4/21 I was experiencing a temperature of 102.5, severe headache, severe muscle fatigue, and painful right axillary lymphadenopathy. Although they had almost completely resolved by 11am on 1/4/20, I would describe these side effects to the vaccine as significantly worse than the symptoms of the virus itself. As someone who has a stronger medical background than the general public (I am a 4th year dental student in a patient-facing role and was encouraged by my school to receive the vaccine despite already testing positive), I understood the likelihood of developing side effects to the vaccine and I am still planning on receiving my second dose in three weeks despite already showing clear signs of a strong immune response to the proteins created by the vaccine. The reason why I am writing this is because there was no guidance on recommending that I wait longer than 10 days between testing positive and receiving the vaccine and I am worried that if the general public is allowed to receive the vaccine at this same time interval, there will be a significant number of people who will have similar side effects (worse than those induced by the virus itself) and they will not only refuse a second dose, but could also vocally discourage many people from trusting the vaccine?s safety and benefit. I obviously don?t know what minimum timeframe should be recommended, but from my individual experience, 11 days was not sufficient. I will be happy to follow up if you would like to know how the symptoms fare after my second dose.
PATIENT WAS LIGHT HEADED, FAINTED AND NAUSEOUS. PATIENT THREW UP CLEAR LIQUID.
SYNCOPE: FAINTING, DIZZINESS, PALENESS, VISUAL DISTURBANCES.
About 10 minutes after the vaccine, I had tachycardia and 6 to 8 hours after, I felt extreme fatigue and body aches. I had an elevated temperature that was about 99 degrees. I also had a stiff neck. I did not see a doctor. I took Aleve and lots of fluid and slept. The body aches and temperature lasted about 24 hours and the fatigue lasted about 48 hours.
HIVES OVER WHOLE BODY LIKE A WALKING RASH DESCRIBED AS ALLERGIC REACTION; This spontaneous report received from a patient concerned a 56 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A, and expiry: UNKNOWN) dose was not reported, administered on 05-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 24-MAY-2021, the subject experienced hives over whole body like a walking rash described as allergic reaction. Treatment medications (dates unspecified) included: diphenhydramine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from hives over whole body like a walking rash described as allergic reaction. This report was non-serious.; Sender's Comments: V0: Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
LIGHTEADED, EARS BUZZING, VISION SPOTS, FATIGUE, GAVE JUICE AND RESTED, SYMPTOMS IMPROVED
Very sore shoulder, especially when using arm overhead or removing shirt.  This has continued since then (7 weeks so far).
redness, warmth, swelling and tenderness to right upper extremity - started within 12 hours of injection (that evening)
Td & MR 1SEP93 pt later reported to secretary itching, redness & whelps; several attempts to contact pt did not return call;
Left Femoral Neck Fracture. On 11/3/2023, patient notes as mildly intoxicated at home. Patient tripped and fell while putting on pants, landing directly on his left hip. Patient presented to the ED 11/3/2023 with concern of fall and left leg pain. Patient denied striking head of loss of consciousness. At time of admission, patient denied any symptoms prior to the fall including chest pain, shortness of breath, dizziness, or lightheadedness. X-ray of hip showed left femoral neck fracture. On 11/4/2023, patient underwent uncomplicated left hip hemiarthroplasty. Patient is attending physical therapy and in admission with concern of fall risk. Admission is ongoing at time of this report. Barriers to Discharge Home: Safety concerns, Fall risk, Current functional status, Inaccessible home environment, Limited caregiver availability Pain limiting progress at this time. On 07/19/2022, subject received the Janssen Ad26.CoV2.S vaccine for a research study.
Pt reported feeling lightheaded, diaphoretic with an elevated HR, about 20 minutes after vaccine administration. Pt received the Tdap (Sanofi Pasteur). HR 120 by palpation. Doctor present, took pt to downstairs doctor's office - EKG completed. No rash, no throat, no tongue, facial swelling. 1500 BENADRYL 50mg PO per Dr.
Headache, Fever, Diarrhea, NauseaVomiting, CHILLS Narrative:
This spontaneous report as received from a pharmacist via a company representative refers to a 64 year old female patient. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with ZOSTAVAX (lot # M014310, expiration date unknown, dose and route of administration were not reported). On an unknown date, the patient and developed a 3 inch to 4 inch area of redness and itching. The pharmacist recommended patient take BENADRYL for the itching and redness and MOTRIN if any pain. The patient did not seek doctor care. On an unknown date, the patient recovered from the events. No product quality complaint (PQC) was involved. No further information was available. The relatedness between the events and ZOSTAVAX was not reported. Additional information has been requested.
HPV inject prick to removal of vaccine appeared pale and entire shot completed and fainted (fainting time < 5 sec.), rested and 100% recovery.
Large, painful, red, itchy, hot rash on arm at site of injection. Has gotten bigger and itchier and hurts more every day,
Felt achy; Dizzy when stands up; Upset stomach; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 24th August 2022, the patient received Shingrix. On 25th August 2022, 1 days after receiving Shingrix, the patient experienced pain, dizziness upon standing and upset stomach. On an unknown date, the outcome of the pain, dizziness upon standing and upset stomach were not recovered/not resolved.   It was unknown if the reporter considered the pain, dizziness upon standing and upset stomach to be related to Shingrix.     Additional Information: GSK Receipt Date: 25-AUG-2022 Reporter's Comments: This case was reported by the patient's husband interactive digital media. The patient got Shingrix shots yesterday (24th August 2022) and Today (25th August 2022), patient was felt achyand dizzy when stands up and an upset stomach. The reporter asked was this normal.
At around 4 pm on day patient received vaccinations (07/23/12) she had a tactile fever, felt nausea, bilateral arm soreness. Mom states child felt better Tuesday afternoon (07/24/12) up until Wed. afternoon when she developed another tactile fever and red rash/swelling occurred. Seen by pediatrician 07/26/12 - OX - toxicity from vaccines. Tx TYLENOL prn for fever or discomfort. BENADRYL prn for itching and redness. Return if S & S worsen or rash doesn't resolve in 1-2 weeks.
painful Hives from head to toe; low grade fever; This is a spontaneous report from a contactable consumer, the patient. A 43-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 07Apr2021 at 15:00 (at the age of 43-years-old), as a single dose for COVID-19 immunisation. Medical history included chronic hives/ cause unknown. Concomitant medications included fexofenadine hydrochloride (ALLEGRA) and cetirizine hydrochloride (ZYRTEC); both for unspecified indication from unknown date and unknown if ongoing. Prior to vaccination, the patient was not diagnosed with COVID -19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The information on known allergies to medications, food or other products was not applicable. On 08Apr2021 at 11:00,  after the 20 hours mark from the initial vaccine, the patient started breaking out with painful hives from head to toe and did run a low grade fever. The patient could breathe so there was no need to go to the hospital. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event painful hives from head to toe and did run a low grade fever was recovered on an unknown date in Apr2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Fever, Chills, Body Aches through night, Fever lasted from 9pm-130am. Body aches subsided by 5:30am
Pt recvd vax in 1991 & lab eval showed inc liver function studies; remained elevated for 6 to 8 months but had no physical sx; pt stated that internist was not concerned since they returned to nl;
allergic to the vaccine; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP) for a sponsored program (174934). The reporter is the patient.  A 73-year-old female patient received pneumococcal 20-val conj vac (dipht crm197 protein) (PREVNAR 20) (Batch/Lot number: unknown) as dose number unknown, single for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ALLERGY TO VACCINE (non-serious), outcome "unknown", described as "allergic to the vaccine".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.